Research News

A pair of research studies led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, reveal important new findings as to how regeneration of myelin in multiple sclerosis (MS) fails and, potentially, more efficient ways to treat it.

Vaccinations may be dominating the headlines, but clinicians are well aware that an effective treatment for COVID-19 — especially for patients who don’t require hospitalization — is still sorely needed.

Chelsie E. Armbruster, PhD, and Elsa Bou Ghanem, PhD, both assistant professors of microbiology and immunology, are being recognized as highly-promising, early-career scientists in the field of host-microbe interactions by the American Society for Microbiology’s Infection and Immunity (IAI) Journal.

The mental health crisis that has resulted from the imposition of lockdowns and stay-at-home orders due to COVID-19 has been widely observed around the world. 

Researchers from the Jacobs School of Medicine and Biomedical Sciences have found evidence of the so-called California variants of COVID-19 — B.1.427 and B.1.429 — in virus samples of Western New Yorkers who tested positive in January by using genetic sequencing to decode the genes of SARS-CoV-2 and better understand how it is evolving.

The University at Buffalo is playing a key role in helping Western New York defeat the COVID-19 pandemic.

Randomized clinical trials (RCTs) are the undisputed gold standard for determining whether a treatment protocol is effective for a specific disease or condition.

Ruogang Zhao, PhD, associate professor of biomedical engineering, is at the forefront of a technological development that significantly speeds up the production of 3D-printed human tissue and organs.

A COVID-19 vaccine candidate, under development by UB spinoff company POP Biotechnologies Inc. and South Korean biotech company EuBiologics Co. Ltd., has started human trials in South Korea.